- Home
- JMIA vs BHVN Comparison
JMIA vs BHVN Comparison
Compare JMIA & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMIA
- BHVN
- Stock Information
- Founded
- JMIA 2012
- BHVN 2013
- Country
- JMIA Germany
- BHVN United States
- Employees
- JMIA N/A
- BHVN N/A
- Industry
- JMIA Catalog/Specialty Distribution
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- JMIA Consumer Discretionary
- BHVN Health Care
- Exchange
- JMIA Nasdaq
- BHVN Nasdaq
- Market Cap
- JMIA 1.2B
- BHVN 1.1B
- IPO Year
- JMIA 2019
- BHVN 2017
- Fundamental
- Price
- JMIA $11.97
- BHVN $9.59
- Analyst Decision
- JMIA Strong Buy
- BHVN Buy
- Analyst Count
- JMIA 2
- BHVN 16
- Target Price
- JMIA $16.50
- BHVN $31.14
- AVG Volume (30 Days)
- JMIA 3.4M
- BHVN 6.5M
- Earning Date
- JMIA 11-12-2025
- BHVN 11-10-2025
- Dividend Yield
- JMIA N/A
- BHVN N/A
- EPS Growth
- JMIA N/A
- BHVN N/A
- EPS
- JMIA N/A
- BHVN N/A
- Revenue
- JMIA $173,224,000.00
- BHVN N/A
- Revenue This Year
- JMIA $21.84
- BHVN N/A
- Revenue Next Year
- JMIA $12.09
- BHVN $2,079.03
- P/E Ratio
- JMIA N/A
- BHVN N/A
- Revenue Growth
- JMIA N/A
- BHVN N/A
- 52 Week Low
- JMIA $1.60
- BHVN $7.48
- 52 Week High
- JMIA $13.14
- BHVN $47.75
- Technical
- Relative Strength Index (RSI)
- JMIA 60.18
- BHVN 39.00
- Support Level
- JMIA $9.08
- BHVN $9.05
- Resistance Level
- JMIA $10.76
- BHVN $10.28
- Average True Range (ATR)
- JMIA 0.91
- BHVN 0.82
- MACD
- JMIA 0.15
- BHVN 0.22
- Stochastic Oscillator
- JMIA 94.50
- BHVN 75.71
About JMIA Jumia Technologies AG each representing two
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates majority of its revenue from the West Africa segment.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.